Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Favuzza

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic Chemistry|October 24, 2021
Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activityTrent D Ashton, Anna Ngo, Paola Favuzza, et al.
Cell Reports|April 4, 2024
The essential malaria protein PfCyRPA targets glycans to invade erythrocytesChristopher J Day, Paola Favuzza, Sabrina Bielfeld, et al.
Journal of Medicinal Chemistry|February 22, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4Trent D Ashton, Madeline G Dans, Paola Favuzza, et al.
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic Chemistry|October 24, 2021
Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activityTrent D Ashton, Anna Ngo, Paola Favuzza, et al.
Cell Reports|April 4, 2024
The essential malaria protein PfCyRPA targets glycans to invade erythrocytesChristopher J Day, Paola Favuzza, Sabrina Bielfeld, et al.
Journal of Medicinal Chemistry|February 22, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4Trent D Ashton, Madeline G Dans, Paola Favuzza, et al.
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 2